Immunology 1999: Vol 97 Index

9 Pages·1999·2.8 MB·English

Author Index
AALBERSE R.C. see SCHUURMAN J. granulocytemacrophage colony-stimulating factor genetically
ABRAHAMS V.M. see EDWARDS J.C.W modified dendritic cells. 616
AGSTERIBBE E. see DE HAAN L. CAPRON A. see HERMANN I
AKATSUKA Y. see ZHU | CARROLL M. see SHEERIN N.S
ALLEN A. see DAVIES D. CHANG H. see WANG H.
ALLEN J.M. see CAMERON A.J. CHAUDRY I.H. see AYALA A
ALVI S.A., RAJASINGAM D., BROWN N.L., ELDER M.G.., CHEEVER A.W. see MOUNTFORD A.P
BENNETT P.R. & SULLIVAN M. H. F. The production of CHEN B.-C., CHEN Y.-H. & LIN W.-W. Involvement of p38
interleukin-1B from human fetal membranes is not obligatory for mitogen-activated protein kinase in lipopolysaccharide-induced
increased prostaglandin output, 249 iNOS and COX-2 expression in J774 macrophages, 124
AMASAKI H. see MATSUMOTO S. CHEN W. see CAO X
ANASETTI C. see ZHU L. CHEN W.F. seeG E Q
ANDEREGGEN E. see OBERHOLZER J. CHEN Y.-H. see CHEN B.-€
ANDERSEN J.K. see TAKAMATSU H. CHESNE S. see KERBLAT |
ANTTILA M. see PENTTIL, J.M. CHIANG B.-L. see LEE Y.-L
ARIEL A. see RABINOVICH G.A. CHOE LS. see KIM K.D.
ARVIEUX J. see REGNAULT V. CHOE Y.-K. see KIM K.D.
AUSTYN J.M. see HILL M.E. CHONG L.-W. see SHI M.M
AYALA A., CHUNG C.-S., XU Y.X., EVANS T.A., REDMOND CHUNG C.-S. see AYALA A.
K.M. & CHAUDRY I. H. Increased inducible apoptosis in CHUNG S.W. see KANG B.Y.
CD4°~ T lymphocytes during polymicrobial sepsis is mediated by COGNE M. see TROUTAUD D
Fas ligand and not endotoxin, 45 COHEN E.P. see SMITH M.
AZUMA N. see SHIMODA M. CONDE C. see LOPEZ-HOYOS M
COOKE A. see PARISH N.M.
BACA-ESTRADA, M.E. see MUTWIRI G. COOPER J.A. see ZHU L.
BAHR G.M. see HERMANN E. COTTER T.G. see CREAGH E.M.
BANLA M. see SOBOSLAY P.T. COULSON P.S. see MOUNTFORD A.P
BATCHASSI E. see SOBOSLAY P.T. CREAGH E.M. & COTTER T. G. Selective protection by hsp 70
BAUER M., HEEG, K., WAGNER H. & LIPFORD G.B. DNA against cytotoxic drug-, but not Fas-induced T-cell apoptosis. 36
activates human immune cells through a CpG sequence- CRETIN N. see OBERHOLZER J
dependent manner, 699
BEFUS A.D. see WILLS F.L. DAI W.J. & GOTTSTEIN B. Nitric-oxide-mediated
BEGEMANN G. see ZWIRNER J. immunosuppression following murine Echinococcus multilocularis
BEHERA A.K. see KUMAR M. infection, 107
BENNETT P.R. see ALVI S.A. DARCISSAC E. see HERMANN Ef
BESKORWAYNE T. see MUTWIRI G. DAVID B. see TKACZYK C.
BILOTTA S. see FILTEAU S.M. DAVIES D., LARBI K., ALLEN A., SANZ M.-J., WEG V.B..
BIRD C. see MEAGER A. HASKARD D.O., LOBB R.R. & NOURSHARGH S. VCAM-|!
BONATO V.L.D. see SILVA C.L. contributes to rapid eosinophil accumulation induced by the
BORREGO F., ROBERTSON M.J., RITZ J.. PEHA J. & chemoattractants PAF and LTB,: evidence for basal expression
SOLANA R. CD69 is a stimulatory receptor for natural killer of functional VCAM-1 in rat skin, 150
cell and its cytotoxic effect is blocked by CD94 inhibitory DAWS M.R., ERIKSSON M.. OBERG L.. ULLEN A. &
receptor, 159 SENTMAN C.L. H-2D¢ engagement of Ly49A leads directly to
BOURSIER L., DUNN-WALTERS D.K. & SPENCER J Ly49A phosphorylation and recruitment of SHP1, 656
Characteristics of IgV,, genes used by human intestinal plasma cells DE GRUIJL F.R. see GARSSEN J.
from childhood, 558 DE HAAN L., HOLTROP M., VERWEIJ W.R.. AGSTERIBBE f
BRENNAN F.R. see PARISH N.M. & WILSCHUT J. Mucosal immunogenicity and adjuvant activity
BROLIN R.E. see ROBERTS A.I. of the recombinant A subunit of the Escherichia coli heat-labile
BROWN NL. see ALVI S.A. enterotoxin, 706
BUEHLER L. see OBERHOLZER J. DECOURT C. see TROUTAUD D.
BUISMAN A.M., VAN ZWET TH.L., LANGERMANS J.A.M.., DEL CAMPO E.G. see LOPEZ-HOYOS M
GEERTSMA M.F., LEENEN P.J.M. & VAN FURTH R. DEMOTZ S. see MiLLER S.
Different effect of granulocyte colony-stimulating factor or DENYER M.S. see TAKAMATSU H.
bacterial infection on bone-marrow cells of cyclophosphamide- DERETZI G., PELIDOU S.H., ZOU L.P., QUIDING C. & ZHI
treated or irradiated mice, 601 J. Local effects of recombinant rat interleukin-6 on the peripheral
BULLIARD C. see MiLLER S. nervous system, 582
BURCHELL J.M. see SMITH M. DERETZI G., PELIDOU S.H.. ZOU L.-P., QUIDING C.. MIX I
LEVI M., WAHREN B. & ZHU J. Suppression of chronic
CAMBRIDGE G. see EDWARDS J.C.W. experimental autoimmune neuritis by nasally administered
CAMERON A.J. & ALLEN J. M. The human high-affinity recombinant rat interleukin-6, 69
immunoglobulin G receptor activates SH2-containing inositol DI MARCO R. see NICOLETTI F.
phosphatase (SHIP), 641 DI MAURO M. see NICOLETTI F
CAO X., ZHANG W., WANG J., ZHANG M., HUANG X., DILGER P. see MEAGER A.
HAMADA H. & CHEN W. Therapy of established tumour with DIOUF A. see GARRAUD O.
a hybrid cellular vaccine generated by using DROUET C. see KERBLAT I.
715
716 Author Index
DROUET M. see TROUTAUD D. HAO Y.-P. see ZHANG M.
DUBOIS K.A. see KAREM K.L. HARDING C.V. see SONG R.
DUNN-WALTERS D.K. see BOURSIER L. HARUTA H., TACHIBANA H. & YAMADA K. Concanavalin A
stimulation enhanced secondary VJ rearrangement in some
EBERT E.C. see ROBERTS A.I. human plasma B cells without up-regulation of recombination-
EDA S. see KASE T. activating gene expression and V germline transcription, 549
EDWARDS J.C.W., CAMBRIDGE G. & ABRAHAMS V.M. Do HASKARD D.O. see DAVIES D.
self-perpetuating B lymphocytes drive human autoimmune disease?, HE Q. see KIRVESKARI J.
188 HEEG K. see BAUER M.
ELDER M.G. see ALVI S.A. HENRY C.J.K. see FILTEAU S.M.
ERIKSSON M. see DAWS MLR. HERMANN E., DARCISSAC E., IDZIOREK T., CAPRON A. &
ERIKSSON M., RYAN J.C.,. NAKAMURA M.C. & SENTMAN BAHR G. M. Recombinant interleukin-16 selectively modulates
C.L. Ly49A inhibitory receptors redistribute on natural killer surface receptor expression and cytokine release in macrophages
cells during target cell interaction, 341 and dendritic cells, 241
EVANS T.A. see AYALA A. HERSHKOVIZ R. see RABINOVICH G.A.
HILL M.E., FERGUSON D.J.P., AUSTYN J.M., NEWSOM-
FACCIOLI L.H. see SILVA C.L. DAVIS J. & WILLCOX H.N. A. Potent immunostimulatory
FAYEN J.D. & TYKOCINSKI M. L. The expansion of human 76 dendritic cells can be cultured in bulk from progenitors in
T cells in response to Daudi cells requires the participation of normal infant and adult myasthenic human thymus, 325
CD4* T cells, 272 HIMENO K. see ZHANG M.
FERGUSON D.J.P. see HILL M.E. HIRABAYASHI J. see RABINOVICH G.A.
FILTEAU S.M., LIETZ G., MULOKOZI G., BILOTTA S., HIRAHARA K. see SAKAGUCHI M.
HENRY C.J.K. & TOMKINS A. M. Milk cytokines and HIRAI H. see KANDA H.
subclinical breast inflammation in Tanzanian women: effects of HIRANO S. & KANNO S. Syk and paxillin are differentially
dietary red palm oil or sunflower oil supplementation, 595 phosphorylated following adhesion to the plastic substrate in rat
LUITMAN A. see GARSSEN J. alveolar macrophages, 414
“RELINGER J.G. see STOROZYNSKY E. HIROSE K. see MITANI A.
C.-L. see LEE Y.-L. HISAEDA H. see ZHANG M.
KUNAGA T. see TANEGASHIMA A. HOLM I. see GARRAUD O.
HOLTROP M. see DE HAAN L.
GARRAUD O., DIOUF A., HOLM I., NGUER C.M., SPIEGEL HSUEH W. see WANG H.
A.. PERRAUT R. & LONGACRE S. Secretion of parasite- HU C. & SALGAME P. Inability of interleukin-12 to modulate T
specific immunoglobulin G by purified blood B lymphocytes helper 0 effectors to T helper | effectors: a possible distinct
from immune individuals after in vitro simulation with subset of T cells, 84
recombinant Plasmodium falciparum merozoite surface HUANG W. see WANG H.
protein-1,, antigen, 204 HUANG X. see CAO X.
GARRAUD O., DIOUF A., HOLM I., PERRAUT R. & HWANG S.Y. see KANG B.Y.
LONGACRE S§S. Immune responses to Plasmodium HYNES R.O. see KAWASHIMA N.
falciparum—merozoite surface protein | (MSP1) antigen, II.
Induction of parasite-specific immunoglobulin G in unsensitized IDZIOREK T. see HERMANN E.
human B cells after in vitro T-cell priming with MSPI1,,, 497 INOUE Y. see SHIMODA M.
GARSSEN J., VANDEBRIEL R.J., DE GRUIJL F.R., WOLVERS INOUYE S. see SAKAGUCHI M.
D.A.W., VAN DIJK M., FLUITMAN A. & VAN LOVEREN ISENBERG D.A. see RIPLEY B.J.M.
H. UVB exposure-induced systemic modulation of Thl- and ISHIKAWA H. see ZHANG M.
[h2-mediated immune responses, 506 ISTURIZ M.S. see RUBEL C.
GE Q. & CHEN W. F. Phenotypic identification of the subgroups ITO Y. see ZHANG M.
of murine T-cell receptor xB * CD4*CD8~ thymocytes and its
implication in the late stage of thymocyte development, 665 JONES D.R. see ZHANG Y.
GEERTSMA M.F. see BUISMAN A.M. JUNG G. see MiLLER Y.
GEIGER S.M. see SOBOSLAY P.T.
GETAHUN A., LUNDQVIST M., MIDDLETON D., WARR G. KANDA H. see MORINO N.
& PILSTROM L. Influence of the p-chain C-terminal sequence KANDA H., MIMURA T., HAMASAKI K., YAMAMOTO K..,
on polymerization of immunoglobulin M, 408 YAZAKI Y., HIRAI H. & NOJIMA Y. Fyn and Lck tyrosine
GEWURZ H. see ZHANG Y. kinases regulate tyrosine phophorylation of p105“%", a member
GILCHRIST M. see WILLS F.L. of p130* docking protein family, in T-cell receptor-mediated
GODLESKI J.J. see SHI M.M. signalling, 56
GONZALEZ A. see LOPEZ-HOYOS M. KANG A.H. see GUMANOVSKAYA ML.
GONZALEZ-CRUSSI F. see WANG H. KANG B.Y., CHUNG S.W., LIM Y.S., KIM E.J., KIM S.H.,
GOTTSTEIN B. see DAI W.J. HWANG S.Y. & KIM T. S. Interleukin-12-secreting fibroblasts
GOTZE O. see ZWIRNER J. are more efficient than free recombinant interleukin-12 in
GOUGEON M.-L. see NAORA H. inducing the persistent resistance to Mycobacterium avium
GRAHAM R. see SMITH M. complex infection, 474
GRANFORS K. see KIRVESKARI J. KANG K.-W., KIM T.S. & KIM K.-M. Interferon-y and interleukin-
GRASSO S. see NICOLETTI F. 4-targeted gene therapy for the atopic allergic disease, 462
GRIEBEL P. see MUTWIRI G. KANNO C. see SHIMODA M.
GUMANOVSKAYA M.L., MYERS L.K., ROSLONIEC E.F., KANNO S. see HIRANO S.
STUART J.M. & KANG A. H. Intravenous tolerization with KAPP A. see ZWIRNER J.
type II collagen induces interleukin-4 and KARANIKAS V., ROWLEY M.J., MACKAY LR. &
interleukin-10-producing CD4* T cells, 466 LOVELAND B. E. Autoreactive cytotoxic T cells in mice are
induced by immunization with a conserved mitochondrial
HALLIDAY G.M. see LUCAS A.D. enzyme in Freund’s complete adjuvant, 264
HAMADA H. see CAO X. KAREM K.L., DUBOIS K.A., McGILL S.L. & REGNERY R. L.
HAMASAKI K. see KANDA H. Characterization of Bartonella henselae-specific immunity in
see also MORINO N. BALB/c mice, 352
HANNA S.M. see SPILLER O.B. KASAI K.-I. see RABINOVICH G.A.
Author Index
KASE T., SUZUKI Y., KAWAI T., SAKAMOTO T., OHTANI LONGACRE, S. see GARRAUD, O.
K., EDA S., MAEDA A., OKUNO Y., KURIMURA T. & LOPEZ-HOYOMS. , REVILLA C., CONDE C., DEL CAMPO
WAKAMIYA N. Human mannan-binding lectin inhibits the E.G., GONZALEZ A. & MERINO J. Different roles for LFA-|
infection of influenza A virus without complement, 385 and VLA-4 integrins in T-B-cell interactions in vivo, 438
KAWAI T. see KASE T. LORD E.M. see STOROZYNSKY E.
KAWASHIMA N., NIEDERMAN R., HYNES R.O., LOU J. see OBERHOLZER J.
ULLMANN-CULLERE M. & STASHENKO P. Infection- LOVELAND B.E. see KARANIKAS V.
stimulated infraosseus inflammation and bone destruction is LUCAS A.D. & HALLIDAY G. M. Progressor but not regressor
increased in P-/E-selectin knockout mice, 117 skin tumours inhibit Langerhans’ cell migration from epidermis
KERBLAT I., DROUET C., CHESNE S. & MARCHE P. N. to local lymph nodes, 130
Importance of thioredoxin in the proteolysis of an LUDER C.G.K. see SOBOSLAY P.T.
immunoglobulin G as antigen by lysosomal Cys-proteases, 62 LUNDQVIST M. see GETAHUN A.
KIM E.J. see KANG BY.
KIM J.K. see KIM K.D.
MACKAY LR. see KARANIKAS V.
KIM K.D., LEE H.G., KIM J.K., PARK S.N., CHOE I.S., CHOE
MAEDA A. see KASE T.
Y.-K., KIM S.J., LEE E. & LIM J.-S. Enhanced antigen-
MAGRO G. see NICOLETTI F.
presenting activity and tumour necrosis factor-x-independent
MaKELA P.H. see PENTTILA J.M.
activation of dendritic cells following treatment with
Mycobacterium bovis bacillus CalmetteGuérin, 626 MAKI-IKOLA O. see KIRVESKARI J.
KIM K.-M. see KANG K.-W. MARCHE P.N. see KERBLAT I
MATSUDA T. see TONG J.-J.
KIM S.H. see KANG B.Y.
MATSUMOTO S., NANNO M., WATANABE N., MIYASHITA
KIM S.J. see KIM K.D.
KIM T.S. see KANG B.Y. M., AMASAKI H., SUZUKI K. & UMESAKI Y. Physiological
see also KANG K.-W. roles of yé T-cell receptor intraepithelial lymphocytes in
KIMURA Y. see MITANI A. cytoproliferation and differentiation of mouse intestinal epithelial
cells, 18
KIRCHHOFF K. see ZWIRNER J.
MATSUMOTO T. see MORINO N.
KIRVESKARI J., HE Q., LEIRISALO-REPO M., MAKI-IKOLA
see also SAKURAI M.H.
O., WUORELA M., PUTTO-LAURILA A. & GRANFORS K
MATSUSE H. see KUMAR M.
Enterobacterial infection modulates major histocompatibility
McCULLOUGH K.C. see KNOETIG S.M.
complex class I expression on mononuclear cells, 420
McGILL S.L. see KAREM K.L.
KISHI H. see TONG J.-J.
MEAGER A., WADHWA M.., BIRD C., DILGER P., THORPE
KISHIHARA K. see UCHIYAMA H.
R., NEWSOM-DAVIS J. & WILLCOX N. Spontaneously
KIYOHARA H. see SAKURAI M.H.
occurring neutralizing antibodies against granulocyte
KNOETIG S.M., SUMMERFIELD A., SPAGNUOLO-WEAVER
macrophage colony-stimulating factor in patients with
M. & McCULLOUGH K. C. Immunopathogenesis of classical
autoimmune disease, 526
swine fever: role of monocytic cells, 359
MECHERI S. see TKACZYK C.
KOBAYASHI C. see SAKAGUCHI M.
MENTHA G. see OBERHOLZER J.
KONAKA A. see SAKAGUCHI M.
MERINO J. see LOPEZ-HOYOS M.
KONG Y.-Y. see UCHIYAMA H.
MERONI P.L. see NICOLETTI F.
KUMAR M., BEHERA A.K., MATSUSE H., LOCKEY R.F. &
METZLER B. & WRAITH D. C. Inhibition of T-cell
MOHAPATRA SS. A recombinant BCG vaccine generates a
responsiveness by nasal peptide administration: influence of the
Thl-like response and inhibits IgE synthesis in BALB/c mice, 515
thymus and differential recovery of T-cell-dependent functions,
KURIMURA T. see KASE T.
MIDDLETON D. see GETAHUN A.
LANGERMANS J.A.M. see BUISMAN A.M. MILIANI DE MARVAL P. see RUBEL C
LARBI K. see DAVIES D. MIMURA T. see KANDA H.
LATCHMAN DSS. see RIPLEY B.J.M. see also MORINO N.
LE MORVAN C. see TROUTAUD D. MITANI A., NISHIMURA H., HIROSE K., WASHIZU J.,
LEAO S.C. see SILVA C.L KIMURA Y., TANAKA S., YAMAMOTO G., NOGUCHI 1
LECOMPTE T. see REGNAULT V. & YOSHIKAI Y. Interleukin-15 production at the early stage
LEE E. see KIM K.D. after oral infection with Listeria monocytogenes in mice, 92
LEE H.G. see KIM K.D. MIX E. see DERETZI G.
LEE Y.-L., FU C.-L. & CHIANG B.-L. Administration of MIYASHITA M. see MATSUMOTO S.
interleukin-12 exerts a therapeutic instead of a long-term MOHAPATRA S.S. see KUMAR M.
preventive effect on mite Der p | allergen-induced animal model MOREL P. see OBERHOLZER J.
of airway inflammation, 232 MORGAN B.P. see SPILLER O.B.
LEENEN P.J.M. see BUISMAN A.M. MORINO N., MATSUMOTO T., UEKI K., MIMURA T.,
LEIRISALO-REPO M. see KIRVESKARI J. HAMASAKI K., KANDA H., NARUSE T., YAZAKI Y. &
LESLIE R. G. Q. The influence of complement receptor type | NOJIMA Y. Glomerular overexpression and increased tyrosine
(CD35) and decay-accelerating factor (CD55) on complement phosphorylation of focal adhesion kinase p125'** in lupus-prone
receptor type 2- (CD21) mediated alternative pathway activation MRL/MP-Ipr/Ipr mice, 634
by B cells, 371 MOUNTFORD A.P., COULSON P.S., CHEEVER A.W., SHER A...
LEVI M. see DERETZI G. WILSON R.A. & WYNN T. A. Interleukin-12 can directly
LEW L. see MUTWIRI G. induce T-helper | responses in interferon-y (IFN-y) receptor-
LIDER O. see RABINOVICH G.A deficient mice, but requires IFN-y signalling to downregulate
LIETZ G. see FILTEAU S.M. T-helper 2 responses, 588
LIM J.-S. see KIM K.D. MULLER S., DEMOTZ S., BULLIARD C. & VALITUTTI S.
LIM Y.S. see KANG BLY. Kinetics and extent of protein tyrosine kinase activation in
LIMA V.M.F. see SILVA C.L. individual T cells upon antigenic stimulation, 287
LIN W.-W. see CHEN B.-C. MULLER Y., WOLF H., WIERENGA E. & JUNG G. Induction
LINT T.F. see ZHANG Y. of abortive and productive proliferation in resting human 1
LIPFORD G.B. see BAUER M. lymphocytes via CD3 and CD28, 280
LOBB R.R. see DAVIES D. MULOKOZI G. see FILTEAU S.M.
LOCKEY R.F. see KUMAR, M. MURAGUCHI A. see TONG J.-J.
Author Index
MUTWIRIG., WATTS T., LEW L., BESKORWAYNE T., PAPP Z., RAJASINGAM D. see ALVI S.A.
BACA-ESTRADA M.E. & GRIEBEL P. Ileal and jejunal Peyer’s RAUTONEN N. see PENTTILA J.M.
patches play distinct roles in mucosal immunity of sheep, 455 REDMOND K.M. see AYALA A
MYERS L.K. see GUMANOVSKAYA ML. REEVE V.E. see NISHIMURA N.
REGNAULT V., ARVIEUX J., VALLAR L. & LECOMPTE T.
NAKAMURA M..C. see ERIKSSON M. Both kinetic data and epitope mapping provide clues for
NAKANO Y. see ZHANG M. understanding the anti-coagulant effect of five murine
NANNO M. see MATSUMOTO S. monoclonal antibodies to human £,-glycoprotein I, 400
NAORA H. & GOUGEON M.-L. Activation, survival and REGNERY R.L. see KAREM K.L.
apoptosis of CD45RO* and CD45RO™ T cells of human REVILLA C. see LOPEZ-HOYOS M.
immunodeficiency virus-infected individuals: effects of RIESCH S. see SOBOSLAY P.T.
interleukin-15 and comparison with interleukin-2, 181] RIPLEY B.J.M., STEPHANOU A., ISENBERG D.A. &
NARUSE T. see MORINO N. LATCHMAN D. S. Interleukin-10 activates heat shock protein
NEWSOM-DAVIS J. see HILL M.E. 90B gene expression, 226
see also MEAGER A. RITZ J. see BORREGO F.
NGUER C.M. see GARRAUD O. ROBERTS A.I., BROLIN R.E. & EBERT E. C. Integrin %,f,
NICOLETTI F., DI MARCO R., ZACCONE P., MAGRO G., DI (VLA-1) mediates adhesion of activated intraepithelial
MAURO M., GRASSO S. & MERONI P. L. Endogenous lymphocytes to collagen, 679
interleukin-!2 only plays a key pathogenetic role in non-obese ROBERTSON M.J. see BORREGO F.
diabetic mouse diabetes during the very early stages of the ROSLONIEC E.F. see GUMANOVSKAYA ML.
disease, 367 ROWLEY M.J. see KARANIKAS V.
NIEDERMAN R. see KAWASHIMA N. RUBEL C., MILIANI DE MARVAL P., VERMEULEN M.A.,
NIGI H. see SAKAGUCHI M. ISTURIZ M.S. & PALERMO M. S. Lipopolysaccharide
NISHIMURA H. see MITANI A. enhances FeyR-dependent functions in vivo through
see also NISHIMURA N. CD11b/CD18 up-regulation, 429
NISHIMURA N., TOHYAMA C., SATOH M., NISHIMURA H. RYAN J.C. see ERIKSSON M.
& REEVE V. E. Defective immune response and severe skin
damage following UVB irradiation in interleukin-6-deficient
mice, 77 SACKS S.H. see SHEERIN N.S.
NOGUCHI T. see MITANI A. SAITO S. see SAKAGUCHI M.
NOJIMA Y. see KANDA H. SAKAGUCHI M., KOBAYASHI C., INOUYE S., SAITO S.,
HIRAHARA K., SHIRAISHI A., KONAKA A., YAMADA T.
see also MORINO N.
NOMOTO K. see UCHIYAMA H. & NIGI H. The incidence of Japanese cedar pollinosis and
NOURSHARGH S. see DAVIES D. sensitization to the pollen allergens among Japanese monkeys in
a troop, 348
O'MALLEY J.M. see WILLIAMSON E. SAKAI T. see ZHANG M.
OBERG L. see DAWS MLR. SAKAMOTO T. see KASE T.
OBERHOLZER J., YU D., TRIPONEZ F., CRETIN N., SAKURAI M.H., MATSUMOTO T., KIYOHARA H. &
ANDEREGGEN E., MENTHA G., WHITE D., BUEHLER L., YAMADA H. B-cell proliferation activity of pectic
MOREL P. & LOU J. Decomplementation with cobra venom polysaccharide from a medicinal herb, the roots of Bupleurum
factor prolongs survival of xenografted islets in a rat to mouse falcatum L. and its structural requirement, 540
model, 173 SALGAME P. see HU C.
OHTANI K. see KASE T. SANZ M.-J. see DAVIES D.
OKUNO Y. see KASE T. SARVAS M. see PENTTILA J.M.
SATOH M. see NISHIMURA N.
PALERMO M.S. see RUBEL C. SCHULZ-KEY H. see SOBOSLAY P.T.
PAPP Z. see MUTWIRI G. SCHUURMAN J., VAN REE R., PERDOK G.J.,. VAN DOORN
PARISH N.M., BRENNAN F.R. & COOKE A. Anti-CD44 treatment H.R., TAN K.Y. & AALBERSE R. C. Normal human
does not prevent the extravasation of autopathogenic T cells to the immunoglobulin G4 is bispecific: it has two different antigen-
thyroid in experimental autoimmune thyroiditis, 533 combining sites, 693
PARK S.N. see KIM K.D. SENTMAN C.L. see DAWS M.R.
PARKHOUSE R.M.E. see TAKAMATSU H. see also ERIKSSON M.
PAULAUSKIS J.D. see SHI M.M. SHEERIN N.S., SPRINGALL T., CARROLL M. & SACKS S.
PELIDOU S.H. see DERETZI G. Altered distribution of intraglomerular immune complexes in
PENA J. see BORREGO F. C3-deficient mice, 393
PENTTILA J.M., ANTTILA M., VARKILA K.., SHER A. see MOUNTFORD A.P.
PUOLAKKAINEN M., SARVAS M., MAKELA P.H. & SHI M.M., CHONG I.-W., GODLESKI J.J. & PAULAUSKIS
RAUTONEN N. Depletion of CD8~ cells abolishes memory in J. D. Regulation of macrophage inflammatory protein-2 gene
acquired immunity against Chlamydia pneumoniae in BALB/c expression by oxidative stress in rat alveolar macrophages, 309
mice, 490 SHIMODA M., INOUE Y., AZUMA N. & KANNO C. Natural
PERDOK G.J. see SCHUURMAN J. polyreactive immunoglobulin A antibodies produced in mouse
PERONET R. see TKACZYK C. Peyer’s patches, 9
PERRAUT R. see GARRAUD O. SHIRAISHI A. see SAKAGUCHI M.
PILSTROM L. see GETAHUN A. SILVA C.L., BONATO V.L.D., LIMA V.M.F., FACCIOLI L.H. &
PORGADOR A. sce SONG R. LEAO S. C. Characterization of the memory/activated T cells
PUOLAKKAINEN M. see PENTTILA J.M. that mediate the long-lived host response against tuberculosis
PUTTO-LAURILA A. see KIRVESKARI J. after bacillus CalmetteGuérin or DNA vaccination, 573
SMITH M., BURCHELL J.M., GRAHAM R., COHEN E.P. &
QUIDING C. see DERETZI G. TAYLOR-PAPADIMITRIOU J. Expression of B7.1 in a
MUCl-expressing mouse mammary epithelial tumour cell line
RABINOVICH G.A., ARIEL A., HERSHKOVIZ R.., inhibits tumorigenicity but does not induce autoimmunity in
HIRABAYASHI J., KASAI K.-I. & LIDER O. Specific MUCI transgenic mice, 648
inhibition of T-cell adhesion to extracellular matrix and pro- SOBOSLAY P.T., LUDER C.G.K., RIESCH S., GEIGER S.M..,
inflammatory cytokine secretion by human recombinant BANLA M., BATCHASSI E., STADLER A. & SCHULZ-KEY
galectin-1, 100 H. Regulatory effects of Thl-type (IFN-y, IL-12) and Th2-type
Author Index
cytokines (IL-10, IL-13) on parasite-specific cellular VAN ZWET TH.LL. see BUISMAN A.M.
responsiveness in Onchocerca volvulus-infected humans and VANDEBRIEL R.J. see GARSSEN J
exposed endemic controls, 219 VARKILA K. see PENTTILA J.M.
SOLANA R. see BORREGO F. VERMEULEN M.A. see RUBEL C
SONG R., PORGADOR A. & HARDING C. V. Peptide-receptive VERWEIJ W.R. see DE HAAN L.
class I major histocompatibility complex molecules on TAP- VILLA I. see TKACZYK C.
deficient and wild-type cells and their roles in the processing of VINEY J.L. see WILLIAMSON FE
exogenous antigens, 316
SPAGNUOLO-WEAVER M. see KNOETIG S.M WADHWA M. see MEAGER A
SPENCER J. see BOURSIER L. WAGNER H. see BAUER M
SPIEGEL A. see GARRAUD O. WAHREN B. see DERETZI G
WAKAMIYA N. see KASE T.
SPILLER O.B., HANNA S.M. & MORGAN B. P. Tissue
WANG H., TAN X.-D., CHANG H., HUANG W., GONZALEZ-
distribution of the rat analogue of decay-accelerating factor, 374
CRUSSI F. & HSUEH W. Platelet-activating factor receptor
SPRINGALL T. see SHEERIN NS.
mRNA is localized in eosinophils and epithelial ceils in rat small
STADLER A. see SOBOSLAY P.T.
intestine: regulation by dexamethasone and gut flora, 447
STASHENKO P. see KAWASHIMA N. WANG J. see CAO X.
STEPHANOU A. see RIPLEY B.J.M. WARR G. see GETAHUN A
STOROZYNSKY E., WOODWARD J.G., FRELINGER J.G. & WASHIZU J. see MITANI A.
LORD E. M. Interleukin-3 and granulocyte-macrophage colony- WATANABE N. see MATSUMOTO S
stimulating factor enhance the generation and function of WATTS T. see MUTWIRI G.
dendritic cells, 138 WEG V.B. see DAVIES D.
STUART J.M. see GUMANOVSKAYA ML. WERFEL T. see ZWIRNER J.
SUANKRATAY C. see ZHANG Y. WHITE D. see OBERHOLZER J
SUGIMACHI K. see UCHIYAMA H. WIERENGA E. see MULLER ¥
SULLIVAN M.H.F. see ALVI S.A. WILLCOX H.N.A. see HILL M.E
SUMMERFIELD A. see KNOETIG S.M. WILLCOX N. see MEAGER A
SUZUKI K. see MATSUMOTO S. WILLIAMSON E., O'MALLEY J.M. & VINEY J
SUZUKI Y. see KASE T the T-cell response elicited by oral administration of
protein antigen, 565
TACHIBANA H. see HARUTA H. WILLS F.L., GILCHRIST M. & BEFUS A. D. Interferon
TAKAMATSU H., ANDERSEN J.K., DENYER M.S. & regulates the interaction of RBL-2H3 cells with fibronectin
PARKHOUSE R. M. E. Establishment of long-term through production of nitric oxide, 481
CD154-dependent porcine B-cell cultures, 211] WILSCHUT J. see DE HAAN L
TAN K.Y. see SCHUURMAN J. WILSON R.A. see MOUNTFORD A.P
TAN X.-D. see WANG H. WOLF H. see MULLER Y
TANAKA S. see MITANI A WOLVERS D.A.W. see GARSSEN J
WOODWARD J.G. see STOROZYNSKY |
TAA NEGASHIMA A., YAMASHITA A., YAMAMOTO H. &
WRAITH D.C. see METZLER B.
FUKUNAGA T. Human parathymic lymph node:
WUORELA M. see KIRVESKARI J.
morphological and functional significance, 301
WYNN T.A. see MOUNTFORD A.P
TAYLOR-PAPADIMITRIOU J. see SMITH M.
THORPE R. see MEAGER A. XU Y.X. see AYALA A.
TKACZYK C., VILLA I., PERONET R., DAVID B. &
MECHERI S. Fee RI-mediated antigen endocytosis turns AMADA H. see SAKURAI M.H
interferon-y-treated mouse mast cells from inefficient into potent AMADA K. see HARUTA H
antigen-presenting cells, 333 AMADA T. see SAKAGUCHI M
TOHYAMA C. see NISHIMURA N. AMAMOTOG . see MITANI A
TOMKINS A.M. see FILTEAU S.M. “AMAMOTO H. see TANEGASHIMA A
TONG J.-J.. KISH] H.,. MATSUDA T. & MURAGUCHI A. A AMAMOTO K. see KANDA H
bone marrow-derived stroma cell line, ST2, can support the AMASHITA A. see TANEGASHIMA A
differentiation of fetal thymocytes from the CD4— CD8™ double iAZAKI Y. see KANDA H
negative to the CD4~ CD8~* double positive differentiation stage see also MORINON.
in vitro, 672 YOSHIKAI Y. see MITANI A
TRIPONEZ F. see OBERHOLZER J YU D. see OBERHOLZER J.
TROUTAUD D., DROUET M., DECOURT C., LE MORVAN C YU X. see ZHU L.
& COGNE M. Age-related alterations of somatic hypermutation
ZACCONE P. see NICOLETTI
and CDR3 lengths in human V«4-expressing B lymphocytes, 197
ZHANG M. see CAO X.
TUTEJA R. B-cell responses to a peptide epitope: mutations in
ZHANG M.. HISAEDA H., SAKAI T., ISHIKAWA H., HAO
heavy chain alone lead to maturation of antibody responses, |
Y.-P.,. NAKANO Y., ITO Y. & HIMENO K. Macrophages
TYKOCINSKI M.L. see FAYEN J.D.
expressing heat-shock protein 65 play an essential role in
protection of mice infected with Plasmodium yoelii, 611
UCHIYAMA H., KONG Y.-Y., KISHIHARA K., SUGIMACHI K.
ZHANG W. see CAO X.
& NOMOTO K. Approach to withdrawal from tacrolimus in a
ZHANG X.-H. see ZHANG Y.
fully allogeneic murine skin graft model, 294 ZHANG Y., SUANKRATAY C., ZHANG X.-H., JONES D.R..
.. see MORINO N. LINT T.F. & GEWURZ H. Calcium-independent haemolysis via
.EN A. see DAWS MR. the lectin pathway of complement activation in the guinea pig
-MANN-CULLERE M. see KAWASHIMA N. and other species, 686
ESAKI Y. see MATSUMOTO S. ZHU J. see DERETZI G.
ZHU L., YU X., AKATSUKA Y., COOPER J.A. & ANASETTI
TUTTI S. see MULLER S. C. Role of mitogen-activated protein kinases in activation-
-LAR L. see REGNAULT V. induced apoptosis of T cells, 26
DIJK M. see GARSSEN J. ZOU L.P. see DERETZI G.
{ DOORN H.R. see SCHUURMAN J. ZWIRNER J., GOTZE O.. BEGEMANN G., KAPP A..
1 FURTH R. see BUISMAN A.M. KIRCHHOFF K. & WERFEL T. Evaluation of C3a receptor
LOVEREN H. see GARSSEN J. expression on human leucocytes by the use of novel monoclonal
1 REE R. see SCHUURMAN J. antibodies, 166

Subject Index
Anticoagulant effect: in atopy, 462
of monoclonal antibodies to human £,-glycoprotein I, 400 Granulocyte colony-stimulating factor:
Apoptosis, T cell, inducible: effect on bone marrow cells, 601
during sepsis, 45 Granulocyte-macrophage colony-stimulating factor, antibodies t )
Autoimmune neuritis, experimental: in autoimmune disease, 526
suppression by intranasal interleukin-6, 69
Autoimmunity: H-2D¢
and self-perpetuating B lymphocytes, 188 induction of Ly49A phosphorylation and SHP! recruitment.
Autoreactive cytotoxic T cells: Heat shock protein 65 expression, macrophage
adjuvant induced, 264 in severe malaria, 611
Heat shock protein 70
B7.1 expression in MUCI mouse mammary tumour, 648 protection against T-cell apoptosis, 36
Bacillus Calmette-Guérin, recombinant: Heavy-chain mutations:
generation of T helper |-type response, 515 and maturation of antibody responses, |
Bartonella henselae:
specific immunity in BALB/C mice, 352 Immune complexes, glomerular, distribution
B-cell lines, porcine: in C3-deficient mice, 393
long term, 211 Immunoglobulin G4, human:
bispecificity, 693
C3a receptor expression: Immunoglobulin M polymerization:
on human leucocytes, 166 influence of pt-chain C-terminus, 408
CasL, tyrosine phosphorylation of: Immunosuppression, nitric oxide mediated
regulation by tyrosine kinase, 56 in alveolar Echinococcus multilocularis, 107
CD3 and CD28: Integrins, LFA-1 and VLA-4
role in proliferation of human T cells, 280 roles in T-B interactions, 438
CD69: Interferon-y:
in natural killer cell activation and cytotoxicity, 159 regulation of mast cell adhesion, 481
Chlamydia pneumoniae in mice: Interleukin-16 and prostaglandin output from human f
role of CD8* T cells, 490 membranes, 249
Collagen-induced arthritis: Interleukin-6:
tolerance in, 466 effects on peripheral nervous system, 582
Complement receptor type | and decay-accelerating factor Interleukin-6-deficient mice:
influence on B-cell activation, 371 effects on immune responses of UVB radiation, 77
Cytokines, milk, and subclinical breast inflammation Interleukin-10:
effects of dietary supplementation, 595 activation of heat shock protein 90B gene expression, 2
Interleukin-12:
Decay-accelerating factor, rat analogue: effects on human T-cell clones, 84 effects on mite-induced ait wal
tissue distribution, 374 inflammation, 232 induction of T helper | responses.
Dendritic cells: non-obese diabetic mouse insulin-dependent diabetes melitus,
enhancement by cytokines, 138 367
Dendritic cell-based tumour vaccine, 616 Interleukin-12-secreting cells:
Dendritic cells, human: resistance to Mycobacterium avium complex, 474
bulk culture, 325 characterization and activation by bacillus Interleukin-15:
Calmette-Gueérin, 626 in oral Listeria monocytogenes infection, 92
DNA: Interleukin-15 and interleukin-2:
activation of human immune cells through CpG sequence, 699 effects on CD45RO~ and CD45RO™ T cells in human
DNA vaccination: immunodeficiency virus infection, 181
characterization of T-cell response induced by, 573 Interleukin-16:
effects on macrophages and dendritic cells, 241
Enterotoxin, heat labile: Intestinal epithelial cells:
mucosal adjuvanticity, 706 regulation by y6 T-cell receptors, 18
Experimental autoimmune thyroiditis:
anti-CD44 and autopathogenic T cells, 533 Langerhan’s cell migration:
inhibition by skin tumours, 130
FceRI-dependent antigen presentation: Lectin pathway, of complement activation:
to mast cells, 333 haemolysis in the absence of calcium, 686
FeyRI, high-affinity receptor: Light chain diversity:
activation of SHIP, 641 and senescence, 197
Focal adhesion kinase: Lipopolysaccharide:
in lupus-prone mice, 634 enhancement of FeyR-dependent functions, 429
Lymph node, parathymic, human:
Galectin-|: significance of, 301
immunological properties, 100
76 T cell, expansion: Macrophage inflammatory protein-2 gene expression:
requirements for CD4~ T cells, 272 regulation by oxidative stress, 309
Gene therapy, interferon-y and interleukin-4 targeted: Macrophages, alveolar:
Subject Index
differential phosphorylation of syk and paxillin, 414 Protein tyrosine kinase activation:
Major histocompatibility complex class I expression: in single T lymphocytes, 287
and enterobacterial infection, 420
Major histocompatibility complex class I, peptide receptive:
Selectin P/E, knockout mice:
and antigen processing, 316
bone destruction in, 117
Mannan-binding lectin:
Swine fever, classical:
anti-influenza A activities, 385
role of monocyte cells, 359
MAP kineases:
in T-cell apoptosis, 26
Mitogen-activated protein kinase, p38: Tacrolimus withdrawal:
involvement in iNOS and COX-2 expression, 124 in murine skin grafting, 294
T-cell differentiation:
Natural killer cells, Ly49A inhibitory receptors: on bone marrow-derived stroma cells, 672
redistribution, 34] T-cell responses:
to oral antigen, 565
Onchocerciasis: Thioredoxin:
regulatory effects of cytokines, 219 in immunoglobulin proteolysis, 62
Thymocyte development:
Pectin polysaccharide: identification of T-cell receptor «B*CD4*CD8~ thymocytes, 665
effect on B-cell proliferation, 540 Tolerance, T helper:
Peyer’s patches, sheep: analysis following nasal administration of peptide, 257
and mucosal immunity, 455
Plasma cells, human intestinal: UVB exposure:
use of immunoglobulin V,, genes, 558 modulation of T helper | and T helper 2 responses, 801
Plasmodium falciparum merozite surface protein-| antigen:
immune responses to, 497
Plasmodium falciparum merozite surface protein-1,, antigen: Vascular cell adhesion molecule:
antibody responses to, 204 and chemoattractant-induced eosinophil accumulation, 150
Platelet-activating factor receptor: Very late activation antigen-|:
localization and regulation, 447 mediation of adhesion of intraepithelial lymphocytes to collagen,
679
Pollinosis and sensitization:
incidence in monkeys, 348 V,J, rearrangement:
Pollinosis, monkey: in some human plasma B cells, 549
prevalence of, 5
Polyreactive antibody, immunoglobulin A: Xenografted islets:
natural, 9 survival following cobra venom factor decomplementation, 173